PW Medtech Group (FRA:PWE) Total Stockholders Equity : €519.41 Mil (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is PW Medtech Group Total Stockholders Equity?

PW Medtech Group's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €519.41 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. PW Medtech Group's Book Value per Share for the quarter that ended in Dec. 2023 was €0.33. The ratio of a company's debt over equity can be used to measure how leveraged this company is. PW Medtech Group's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.00.

PW Medtech Group Total Stockholders Equity Historical Data

The historical data trend for PW Medtech Group's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PW Medtech Group Total Stockholders Equity Chart

PW Medtech Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

591.38

642.14

526.94

534.20

519.41

PW Medtech Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															526.94	550.55	534.20	515.32	519.41

PW Medtech Group (FRA:PWE) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

PW Medtech Group's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(519.406	-	0)	/	1565.63
	=	0.33

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

PW Medtech Group's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.097	+	0.047)	/	519.406
	=	0.00

PW Medtech Group Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of PW Medtech Group's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PW Medtech Group (FRA:PWE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PW Medtech Group Ltd (FRA:PWE) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

01358:Hong Kong

Address

Building 1, No. 23 Panlong West Road, Pinggu District, Beijing, CHN, 101204

Website

https://www.pwmedtech.com

PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the advanced infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business.

PW Medtech Group (FRA:PWE) Headlines

No Headlines